Usefulness of milnacipran in treating phantom limb pain

Código QR

Usefulness of milnacipran in treating phantom limb pain

Yasuhide Nagoshi,1 Akira Watanabe,1 Saiko Inoue,1 Tomoki Kuroda,2 Mitsuo Nakamura,3 Yoshitake Matsumoto,4 Kenji Fukui31Department of Psychiatry (Psychosomatic Medicine), Kyoto First Red Cross Hospital, Kyoto, Japan; 2Gojouyama Hospital, Nara, Japan; 3Department of Psychiatry, Graduate School of Medi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Matsumoto Y, Nakamura M, Kuroda T, Inoue S, Watanabe A, Nagoshi Y, Fukui K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/fae64bf68a9a4a25a2dda30805bcfa27
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Milnacipran: recent findings in depression
por: Guest editors: Stuart Montgomery (London, et al.
Publicado: (2010)

Antidepressant therapy with milnacipran and venlafaxine
por: Lucilla Mansuy
Publicado: (2010)

Milnacipran: a unique antidepressant?
por: Siegfried Kasper, et al.
Publicado: (2010)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
por: Kitaichi Y, et al.
Publicado: (2012)

Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study
por: Jiang S, et al.
Publicado: (2021)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Jay D Kranzler, et al.
Publicado: (2010)

Editorial Foreword - Milnacipran: recent findings in depression
por: Stuart Montgomery, et al.
Publicado: (2010)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper S, et al.
Publicado: (2011)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Peter Hofmann
Publicado: (2010)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Alla Avedisova, et al.
Publicado: (2009)

Effects of milnacipran on binge eating &ndash; a pilot study
por: Shun&rsquo;ichi Noma, et al.
Publicado: (2008)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
por: Kamijima K, et al.
Publicado: (2013)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
por: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et al.
Publicado: (2009)

Possible association between phantom vibration syndrome and occupational burnout
por: Chen CP, et al.
Publicado: (2014)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Philippe Courtet
Publicado: (2010)

Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants &ndash; a case series
por: Kirino E, et al.
Publicado: (2011)

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
por: Heidemarie Abrahamian, et al.
Publicado: (2009)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian H, et al.
Publicado: (2012)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
por: Ogawa K, et al.
Publicado: (2015)

Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
por: Jean-Pierre Oli&eacute;, et al.
Publicado: (2010)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo S, et al.
Publicado: (2015)

Assessment of anxiety and depression after lower limb amputation in Jordanian patients
por: Ziad M Hawamdeh, et al.
Publicado: (2008)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
por: Hashimoto T, et al.
Publicado: (2015)

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity
por: Veauthier C, et al.
Publicado: (2015)

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors
por: Komada Y, et al.
Publicado: (2015)

Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome
por: G&uuml;rsoy AE, et al.
Publicado: (2013)

Life satisfaction in patients with chronic pain &ndash; relation to pain intensity, disability, and psychological factors
por: St&aring;lnacke BM
Publicado: (2011)

Childhood adversities and laboratory pain perception
por: Pieritz K, et al.
Publicado: (2015)

Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
por: Britt-Marie St&aring;lnacke, et al.
Publicado: (2010)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew Y, et al.
Publicado: (2015)

Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents
por: Furukawa TA, et al.
Publicado: (2012)

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: &Uuml;nsal C, et al.
Publicado: (2013)

Duloxetine in panic disorder with somatic gastric pain
por: Preve M, et al.
Publicado: (2013)

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
por: Tanamachi Y, et al.
Publicado: (2015)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa R, et al.
Publicado: (2015)

Reduced dorsolateral prefrontal cortical hemodynamic response in adult obsessive-compulsive disorder as measured by near-infrared spectroscopy during the verbal fluency task
por: Hirosawa R, et al.
Publicado: (2013)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Takahashi M, et al.
Publicado: (2012)

Clinical use of pregabalin in the management of central neuropathic pain
por: Nanna B Finnerup, et al.
Publicado: (2007)